ABSTRACT Background: Diseases caused by opportunistic pathogens are the major clinical signs of HIV infected and AIDS patients with parasitic infection being part of the common causes of morbidity and mortality.
INTRODUCTION
Infections caused by these parasites Toxoplasma gondii, Schistosoma sp. and Entamoeba histolytica have been characterized as opportunistic infection in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients around the world (1, 2, 3). The major clinical manifestation of HIV infection as well as in AIDS patients is diseases caused by opportunistic pathogens and parasitic coinfections constituted part of the common causes of morbidity and mortality ( 4, 5) .
Toxoplasmosis is a typical disease that affects humans, with most cases asymptomatic. While the prevalence of Toxoplasma antibodies correspond with age, it does not correspond with sex; variations and differences exist in each country. In part of sub-Saharan Africa with moist weather, variations in toxoplasmosis prevalence ranges between 50% and 70% and the estimated population risk and infection is one third and half among worldwide population (6) . The incidence of sero-positivity varies in humans, showing previous exposure and location in addition to eating habits (7, 8) . Previous studies demonstrated the common cause of focal lesions of the brain as a result of Toxoplasma encephalitis and thereby complicating the direction of AIDS due to the reactivation of a latent infection (9, 10) . In advanced stage with Toxoplasma encephalitis recrudescent toxoplasmosis usually manifest as cerebral abscess impairing the immune responses to infections causing the infective reactivation in AIDS patients through immune suppression (2, 11, 12 (14) . Earlier studies demonstrated that urinary schistosomiasis occurs more than intestinal schistosomiasis in Nigeria (15, 16) . Both HIV/AIDS and schistosomiasis causes significant disease burden in sub-Saharan Africa with frequent overlap in their epidemiological characteristics 17 . While few studies have examined interaction between the two diseases (3, 15, 16, 17, 18, 19) , studies have shown that both diseases exert bi-directional effects on one another (20, 21).
Entamoeba histolytica primarily inhabits the large intestine where the trophozoites or active forms live. Studies have shown that morphologically identical pathogenic and non-pathogenic strains of amoebae that are genetically, biochemically and immunologically distinguishable exist (22, 23, 24) . However, the same strain can change its behavior within the same host from time to time. Hence, there is no doubt that immunosuppression of the host can turn a harmless commensal infection into a dangerously invasive one (1, 25, 26) . Invasive amoebiasis (IA) is a significant parasitic infection that is associated with significant morbidity and mortality world-wide in individuals that resides or travels to endemic areas and it accounts for 40,000 to 100,000 deaths annually. IA had previously been reported in HIV infected / AIDS patients (27, 28, 29, 30) .
While some work had been conducted on these parasitic infections in Nigeria, few of such studies had been carried out comparatively in HIV infected and non-infected individuals in the country. Hence, the objective of this study was aimed at determining the sero-prevalence of these three parasitic infections among HIV seropositive and sero-negative patients using serodiagnostic approach to determine the presence of serum antbody to these infections.
Research
Method and Design Study design This was a cross-sectional based study that was designed to carry out sero-prevalence of serum antibodies to three parasitic infections namely Entamoeba histolytica, Schistosoma sp. and Toxoplasma gondii using serodiagnostic approach. Details of the study design and population have been published previously 31 . Briefly, patients attending three health-care institutions in Lagos, Nigeria namely, General Hospital Ikeja, Sexually Transmitted Diseases Clinic Yaba, and the Central Public Health Laboratory Yaba were recruited for the study through the convenient sampling method between January 1996 and December 1997. The selected institutions serve as: (i) provider-based facility, (ii) referral centre for HIV and STD patients, and (iii) client based facility especially for people who intend to be familiar with their HIV and STD statuses.
Blood samples for screening of HIV, Toxoplasma gondii, Schistosoma sp, and Entamoeba histolytica were obtained with consent from 1080 patients out of 200 patients interviewed. Written informed consent or thumbprints were received from all recruited individuals and consent could not be obtained from 920 patients who declined to participate and were excluded from the study. Both patients who refused to be recruited for the study and those who were sero-positive in the study were given adequate clinical services.
Laboratory procedures Blood sera of the patients were screened for HIV-1 and HIV-2 using Cambridge Biotech Corporation Recombigen HIV-1 and HIV-2 rapid test device while confirmation of positive cases was done with Immunocomb 11 and Bio-rad Novapath HIV-1 immunoblot for HIV-2 and HIV-1, respectively. Diagnosis of parasitic infections from blood sera of sampled patients was done by Indirect Haemaglutination (IHA) method. The IHA principle involves the use of reagent made of formalized sheep blood cells, which are sensitized by a soluble antigen of the parasite and made to react with antibodies present in the patient with the formation of a haemagglutination i.e. a reddish-brown film that is observed in the wells of a U-microplate. In the absence of specific antibodies, the sensitized red blood cells will deposit, by forming a ring in the bottom of the well.
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RESULTS
Of the sampled patients (aged 4 to 62 years), 36/1080 (3.3%) were males and 29/1080 (2.7%) were females. Titer values ranged from 1:16 to 1:4096. Out of the total patients screened for HIV in the study, 65 (6%) were sero-positive. Among the 65 patients with confirmed HIV sero-positive results, 8 (12.3%) had three parasitic co-infections while among the 1015 patients without HIV infections, 34 (3.3%) had the three infections (Table 1) .
Sero-diagnosis assay from the study showed that 5 (7.7%) of patients with HIV sero-positive result had serum antibodies to E. histolytica (Table 1) . Titer values of serum antibodies to E. histolytica infection ranged from 1:16 to 1:512 for the sampled patients. A significant titer value range of 1:32 to 1:512 was found in 5 (0.5%) HIV seronegative patients, while 3 (4.6%) HIV seropositive patients had a significant titer value of 1:256 to 1:512 for E. histolytica serum antibody (Table 2 ).
Only 4 (0.4%) HIV sero-negative patients and 1 (1.5%) HIV sero-positive patients had serum antibodies to Schistosoma sp. infection (Table 1) . Among HIV sero-negative patients 3 (0.3%) had a titer of 1:16 while only 1 (0.1%) patient had a higher titer of 1:256. Titer value in the HIV seropositive patient was 1:16 (Table 2) . Serum antibodies to T. gondii infection were found in 2 (3.1%) of HIV sero-positive patients and in 6 (0.6%) of the sero-negative patients with titer value range of 1:16 to 1: 128 (Table 1 ). Significant titer value of ≥ 1:64 Toxo kit and >0.9 Toxo IgM kit interpretations was recorded in 1 (0.1%) HIV sero-negative patient and 2 (3.1%) HIV sero-positive patients (Tables 2). Result from the study also showed that more patients within the age range 21-30 years in both HIV sero-positive and sero-negative patients had serum antibody to T. gondii infection (Table 3) . Also, more females than males presented with antibodies to T. gondii infection in HIV seropositive 2 (3.1%) and HIV sero-negative 5 (0.5%) patients. (Table 4 ). 
TABLE 2: TITER VALUES OF SAMPLED PATIENTS SHOWING SERO-POSITIVITY FOR PARASITIC INFECTIONS

DISCUSSION
The presence of significant serum antibody to E. histolytica and T. gondii among HIV sero-positive patients in the study has further exposed these two parasitic organisms as possible opportunistic infections in HIV infected / AIDS patients as previously reported (1, 2) . Medical practitioners in this region should focus attention on the diagnosis of these organisms and clinical management of infection with these organisms as well as other endemic diseases like malaria and tuberculosis that may interact or be opportunistic in HIV infected and AIDS patients.
The significant titer value of 1:32 or more recorded in this study in HIV sero-positive as well as in HIV sero-negative patients is an indication of the presence of invasive E. histolytica. Clinical manifestations associated with E. histolytica infection could result in asymptomatic and symptomatic infection with or without tissue invasion. E. histolytica may remain a harmless commensal in its host or may become pathogenic due to certain factors not fully understood; however, immunosuppression had been described as a factor that could turn harmless commensal E. histolytica into a dangerously invasive one. Majority of infection with E. histolytica are asymptomatic and such individuals will have a negative or weak serologic response and will primarily pass cysts in their stools 38, 39 . In one study, asymptomatic HIV-1 infected individuals with high anti-Eh titer were reported to be at risk of IA, perhaps as a result of exacerbation of subclinical amebiasis (27) . In another study, the main presenting symptoms of IA were reported as fever, chronic diarrhea, and abdominal pain (29) .
Only 1.5% of the HIV sero-positive patients in the study had serum antibody to Schistosoma sp. infection as compared with 0.6% of HIV seronegative patients that had serum antibody. Both urogenital and intestinal schistosomiasis are chronic inflammatory disease caused by a waterborne parasitic blood fluke with about 220 million people infected in sub-Saharan Africa, and more people especially children at risk (17) . (3, 17, 40) .
Indications for the presence of T. gondii infection was found in two patients that were sero-positive for HIV and one patient that was sero-negative for HIV with a significant titer value. In the diagnosis of T. gondii infection, a negative IgM indicates absence of infection in the past 6 months while a combination of positive IgM and IgG titer indicates acute infection (41, 42, 43) . A positive IgG test with a negative IgM indicates chronic infection (12) . This result thus supports the presence of T. gondii infection in HIV infection in the area. A sero-prevalence of 58% was reported for Toxo-IgG antibodies among HIV patients without neurological complications in Lagos, Nigeria (44) . Although more females than males in this study presented with serum antibodies to T. gondii infection, studies have shown that there is little or no difference in the prevalence of T. gondii infection between sexes (6).
Limitation
Limitation of this study includes the inability to investigate factors like education, nutrition, environmental and behavioral attitudes that can influence the rate differences between HIV infected and HIV non-infected patients in the study. Furthermore, serology positive tests for parasitic infections in the study could not be confirmed with more specific test due to limited resources. Another limitation is the low sensitivity and specificity of serological diagnosis of parasitic infections (45) . In addition, sample sizes of HIV positive for uncommon parasites were very small.
Recommendation
Information on the prevalence of these diseases among HIV infected patients is scanty in the area; with a population of over 150 million and HIV prevalence of 3.1% among adults ages 15-49 reported in 2012 46 , more studies are required on these diseases by location in different part of the country.
Conclusion
We have therefore been able to further determine the sero-prevalence as well as demonstrate the presence of the three parasitic infections in the area most especially among HIV infected patients using serodiagnosis technique which is considered to be the most available and affordable routine method of diagnosing diseases like Toxoplasmosis in resource poor countries (37) and as well help guide therapeutic and management policies for infected patients in the area. 
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